Related by context. All words. (Click for frequent words.) 68 oxycodone CR 65 mg Proellex 65 % Confidence Interval 64 achieved ACR# 64 mg TID 64 salmeterol fluticasone 63 NNT = 63 highly emetogenic 63 mg/# hours 63 mcg albinterferon alfa 2b 63 lopinavir r arm 63 μg d 62 NPH insulin 62 lumbar spine BMD 62 Pharmacokinetic parameters 62 atorvastatin #mg 62 ALT elevation 62 MMSE score 62 abacavir lamivudine 62 tolterodine ER 61 FDA defined valvulopathy 61 μmol L 61 MADRS score 61 REYATAZ r arm 61 achieved statistical significance 61 ‰ ¥ 61 -#.# mg dL [001] 61 receiving ISENTRESS 61 mcg QD 61 morphometric vertebral fractures 61 receiving VICTRELIS 61 #mg dose [002] 61 mg tid 61 paresthesias 61 #.#mg/dL 61 balsalazide 61 zonisamide SR 61 baseline HbA1c 61 tipranavir r 61 mcg BID 61 alfuzosin 61 mg eq 61 linaclotide treated 61 IRLS score 61 mg BID dose 61 urinary N telopeptide 61 #mg/day [002] 61 quetiapine risperidone 61 PASI scores 61 4mg/kg 61 PRADAXA #mg 61 transaminase elevations 60 constipation nausea 60 titrated glipizide 60 prednisone prednisolone plus 60 pooled comparator 60 Flu Cy 60 mL/min/#.# m 2 60 -#.# mg dL [002] 60 nadroparin 60 fatigue asthenia 60 8mg/kg 60 CR nPR 60 5-FU/LV 60 bupropion SR 60 mcg mL 60 HbA1C levels 60 Hb A1C 60 neutropenia thrombocytopenia 60 glulisine 60 ADCS CGIC 60 hours postdose 60 serum urate 60 doxazosin 60 desvenlafaxine succinate 60 haematologic 60 fluticasone salmeterol 60 paroxetine sertraline 60 PREZISTA r arm 60 Peg IFN 60 baseline FEV 60 â ‰ ¥ 60 oral levofloxacin 60 #mg/day [001] 60 tapentadol ER 60 -#.# log# 60 baseline serum creatinine 60 moderate renal impairment 60 divalproex sodium 59 octreotide LAR 59 serum IGF 59 lispro 59 #OHD 59 SVR# 59 elevated ALT 59 QTcF 59 QTc prolongation 59 MoxDuo TM IR 59 INVEGA ® 59 aspirin clopidogrel 59 imiquimod cream 59 mg p = 59 Mg Uk 59 oral diclofenac 59 cEVR 59 comparator arm 59 statistically significant p = 59 ertapenem 59 #mg doses [002] 59 baseline Hb 59 SGPT 59 receiving XGEVA 59 mmol kg 59 ARB telmisartan 59 pmol L 59 arterial thromboembolic events 59 RLAI 59 mg BID 59 zolmitriptan 59 metformin sulfonylurea 59 Cmax 59 extrapyramidal disorder 59 μg kg 59 ACTEMRA TM 59 log# copies mL 59 prednisone prednisolone 59 BENICAR HCT 59 sumatriptan naproxen sodium 59 hematological parameters 59 hypophosphatemia 59 estimated GFR 59 SSRI SNRI 59 Infusion Reactions Severe 59 adjunctive placebo 59 certolizumab 59 unresectable HCC 59 HBeAg negative patients 59 acetazolamide 59 Alzheimer Disease Assessment 59 serum aminotransferase levels 59 events TEAEs 59 plus prednisone prednisolone 59 intact parathyroid hormone 59 #-#,# mg 59 mmol L. 59 attain statistical significance 59 glycated hemoglobin levels 59 Am J Cardiol 59 TMC# r 59 Posaconazole 59 HBeAg seroconversion 59 aspartate aminotransferase AST 59 headache abdominal pain 59 APTIVUS r 58 rosuvastatin Crestor 58 AUA Symptom Score 58 Serious adverse reactions 58 leukopenia 58 postintervention 58 Engerix B 58 statistical significance p 58 β blockers 58 hypokalemia 58 bezafibrate 58 neutropenia dehydration dyspnea 58 bepotastine besilate nasal spray 58 Known hypersensitivity 58 HOMA IR 58 nondiabetic patients 58 undetectable HBV DNA 58 sUA 58 mmol l 58 AUC0 58 Thal Dex 58 vitreous haze 58 idraparinux 58 #mg #mg #mg [003] 58 ADAS cog 58 TEAEs 58 oral prednisolone 58 corrected QT interval 58 INVEGA ™ 58 oral olanzapine 58 pyrexia mucositis sepsis febrile 58 prolactin levels 58 Effexor venlafaxine 58 mg QD 58 extrapyramidal symptoms 58 infliximab monotherapy 58 nmol l 58 acarbose 58 x ULN 58 AUC0 #hr 58 Apidra ® 58 doxorubicin cyclophosphamide 58 interferon alfa 2b 58 Operative mortality 58 detemir 58 Mg Usa 58 titrated glipizide plus 58 rizatriptan 58 elevated LDH 58 IU ml 58 confidence intervals CIs 58 albumin excretion rate 58 R# #mg BID 58 bovine thrombin 58 serum urate levels 58 ritonavir boosted atazanavir 58 echocardiographic parameters 58 mometasone furoate 58 serum creatinine levels 58 mEq L 58 peginterferon alfa 2b 58 microg 58 Eloxatin R 58 IOP lowering 57 biphasic insulin aspart 57 + PH# 57 pegaptanib 57 ug kg 57 salmeterol fluticasone propionate 57 mg/# h 57 RISPERDAL ® 57 lopinavir r 57 venlafaxine XR 57 CI -#.# 57 tenofovir emtricitabine 57 UPDRS motor 57 HAM D# 57 Sanofi Pasteur Fluzone 57 DAS# remission 57 sulfonylurea metformin 57 achieving PASI 57 subcutaneous insulin 57 isoproterenol 57 hematologic toxicity 57 mmHg diastolic 57 Lantus ® 57 experienced virologic failure 57 transdermal estradiol 57 PREMPRO 57 saline placebo 57 HbA 1c levels 57 micrograms mL 57 elevated serum creatinine 57 steroid dexamethasone 57 lipid lowering agents 57 PENTASA 57 oxycodone IR 57 WOMAC pain 57 nmol liter 57 GSK# [001] 57 ziprasidone 57 P ≤ 57 serum estradiol 57 p = NS 57 hemoglobin A1c HbA1c 57 KETEK 57 High Dose quadruples 57 hepatic enzymes 57 Viread Emtriva 57 diuretic chlorthalidone 57 apolipoprotein B 57 uM 57 #mg BID [001] 57 timolol 57 posttreatment 57 ADAS Cog 57 azilsartan medoxomil 57 mg RDEA# 57 improves glycemic 57 mucosal inflammation 57 postmenopausal osteoporotic women 57 mcg dose 57 tapentadol IR 57 oral prednisone 57 tiotropium bromide 57 nicardipine 57 statin monotherapy 57 PANSS scores 57 DLTs 57 aminotransferases 57 gm dl 57 serum phosphorous 57 fractional shortening 57 trandolapril 57 anemia hemoglobin 57 candesartan cilexetil 57 unfractionated heparin UFH 57 mg Androxal 57 insulin detemir 57 oral antidiabetes 57 MBq 57 inecalcitol 57 abdominal pain flatulence 57 polytherapy 57 Pred Forte 57 mg clopidogrel 57 neuropathy sensory 57 Crohn Disease Activity 57 baseline A1C 57 Tasigna prolongs 57 Ann Intern Med 57 CONCERTA ® 57 #.#g/day 57 glycosylated hemoglobin HbA1c 57 dizziness somnolence 57 dizziness nausea diarrhea 57 bronchodilatory 57 AST ALT 57 β blocker 57 headache somnolence 57 1mg dose 57 sitagliptin Januvia 57 dyspnoea 57 ACTOplus met XR 57 racemic albuterol 56 leukocyte count 56 serum ALT 56 mso footer margin 56 ACEIs 56 detectable HCV RNA 56 A1c levels 56 lymphopenia 56 alanine aminotransferase 56 eosinophil count 56 Pain Intensity 56 concentration Cmax 56 MCyR 56 eszopiclone 56 P = .# 56 warfarin erythromycin 56 benazepril 56 hemoglobin Hb 56 plus OBT 56 nmol L. 56 CDAI score 56 extrapyramidal side 56 timepoints 56 #Gy 56 neutropaenia 56 solifenacin 56 ULORIC 56 Index CDAI 56 adjunctive ABILIFY 56 ug ml 56 anagrelide 56 μg mL 56 UPDRS scores 56 VIIBRYD 56 #ng/ml 56 mL sec 56 Keppra XR 56 pharmacologically active isomer 56 ARCALYST ® 56 pamidronate 56 Provas ® 56 mm Hg diastolic 56 myalgia arthralgia 56 mU liter 56 Non inferiority 56 Pegasys peginterferon alfa 2a 56 baseline LDH 56 Montgomery Åsberg Depression 56 budesonide pMDI 56 ug dose 56 NIHSS score 56 mg Pycnogenol 56 glycosylated hemoglobin levels 56 KRAS mutations occur 56 tamoxifen Nolvadex ® 56 atorvastatin Lipitor 56 Visual Analogue Scale VAS 56 pentoxifylline 56 abdominal distention 56 Stent thrombosis 56 % CI #.#-#.# [003] 56 ritonavir boosted 56 postprocedure 56 nonsignificant difference 56 Treatment discontinuations due 56 transaminases 56 HbA 1c 56 mg simvastatin 56 maximal tolerated 56 nausea dizziness vomiting 56 thrombocytopenia neutropenia 56 hsCRP levels 56 prospectively stratified 56 Lipitor #mg 56 YMRS 56 hypersomnia 56 PANSS total 56 mm Hg systolic 56 PSA nadir 56 neutrophil counts 56 EDSS score 56 Kaplan Meier estimates 56 EDSS scores 56 peginterferon alfa 56 CIMZIA TM certolizumab pegol 56 thienopyridine 56 serum phosphorus 56 serum magnesium 56 p ≤ 56 oral ribavirin 56 Median PFS 56 HADS 56 Ticagrelor 56 cholestyramine 56 analgesic medications 56 maximally tolerated dose 56 channel blocker amlodipine 56 Fibromyalgia Impact Questionnaire 56 rimonabant #mg 56 nadolol 56 Eur J Endocrinol 56 intima media thickness 56 peak plasma concentrations 56 neutropenic fever 56 Zocor simvastatin 56 median survivals 56 IBDQ 56 serum TSH 56 MIC# [001] 56 concomitant AEDs 56 aldosterone antagonist 56 Scale cognitive subscale 56 3mg/kg 56 Primary endpoints 56 DAS# CRP 56 -#.# ± [002] 56 XEPLION R 56 CrCl 56 paresthesia 56 sulphonylureas 56 tamsulosin 56 quetiapine XR 56 biochemical relapse 56 flutamide 56 tacrolimus ointment 56 R adefovir dipivoxil 56 CANCIDAS 56 triiodothyronine 56 postdose 56 oral anticoagulation 56 rFSH 56 HbA 1C 56 multivariable adjusted 56 Rating Scale MADRS 55 somnolence dizziness 55 g dl 55 PEG IFN 55 TMP SMX 55 #.#/#.# mmHg [001] 55 primidone 55 Peripheral edema 55 dexamethasone Decadron 55 hypomagnesemia 55 -#.# log# copies mL 55 guanfacine 55 Hycamtin ® 55 nevirapine Viramune 55 CONCERTA 55 moderately emetogenic 55 ng dl 55 aspartate aminotransferase 55 Acetate Rectal Suppositories 55 superficial edema 55 mean baseline HbA1c 55 PaO 2 55 #.#mmol L [002] 55 mg qd 55 ACR# ACR# 55 creatinine ratio 55 Metoprolol 55 dermatologic toxicities 55 μg L 55 clodronate 55 acute bipolar mania 55 piperacillin tazobactam 55 endoscopic remission 55 microgram kg 55 pegylated interferon alpha 55 aminotransferase levels 55 #mm Hg 55 pT3 55 CIMZIA ™ 55 Brief Psychiatric 55 ADCS ADL 55 atazanavir ritonavir 55 TPV r 55 elevated IOP 55 CIMZIA TM 55 generalized edema 55 nasopharyngitis 55 SCIg 55 rosuvastatin #mg 55 HT 1A 55 insulin lispro 55 tiagabine 55 CCyR 55 plus dexamethasone 55 INEGY 55 GPIIb IIIa inhibitors 55 #μg [001] 55 Triglyceride levels 55 noninferior 55 XIENCE V PROMUS Stent 55 lymphocyte count 55 Myelosuppression 55 cells uL 55 Fasting plasma glucose 55 aplindore 55 mIU mL 55 6MWD 55 locoregional recurrence 55 interleukin IL -6 55 binary restenosis 55 PREZISTA ritonavir 55 thromboembolic 55 Ishak fibrosis score 55 periprocedural 55 mg/m2 dose 55 HDRS 55 mCi 55 headache nasopharyngitis 55 acromegalic patients 55 conjugated equine estrogen 55 ACR# response 55 plasma leptin 55 per deciliter mg 55 dosing cohort 55 PEGINTRON TM 55 achieved mucosal healing 55 ZOMIG 55 MMSE scores 55 serum lipid 55 carbidopa levodopa 55 IV bisphosphonates 55 PANSS 55 Montgomery Asberg Depression 55 symptomatic hypotension 55 femoral neck BMD 55 reduce serum phosphate 55 symptomatic intracranial hemorrhage 55 laboratory abnormalities 55 diarrhea dyspepsia 55 glargine 55 FFNS 55 antibody titer 55 mcg dL 55 evaluable subjects 55 bioavailable testosterone 55 apnea hypopnea index 55 IFN α 55 adriamycin 55 mcg doses 55 p = .# [002] 55 fluoxetine paroxetine 55 mmHg p = 55 IRLS 55 FluCAM arm 55 UPDRS 55 hematological toxicity 55 Adefovir 55 SGRQ 55 fluvastatin 55 ABC/3TC 55 stomatitis pharyngitis 55 angiotensin II receptor blockers 55 angiographic outcomes 55 genotypic resistance 55 beta blocker atenolol 55 mg kg dose 55 coronary stenosis 55 lispro alone 55 prolactin elevation 55 triglyceride TG 55 EXJADE 55 LATUDA 55 mIU ml 55 serum cortisol 55 mRS 55 paliperidone ER 55 Discontinuations due 55 fluticasone propionate FP 55 FUSILEV enhances 55 EFFEXOR XR 55 biopsy Gleason 55 nonobese 55 revascularizations 55 Sinemet 55 low dose Iluvien 55 liver histology 55 Kidney Int 55 intravenous dosing 55 hMG 55 QIDS SR 55 plasma folate 55 REMICADE monotherapy 55 CorVue ™ 55 q8h 55 IIIa inhibitor 55 Key secondary endpoints 55 preoperative PSA 55 pegylated interferons 55 postop 55 CFQ R 55 pCR 55 Febrile neutropenia 55 hyperinsulinemic euglycemic clamp 55 acitretin 55 active comparator 55 symptomatic GERD 55 adefovir treated 55 leukocyte counts 55 femoral neck fracture 54 lacosamide 54 ng dL 54 metformin XR 54 Desvenlafaxine Succinate 54 nmol 54 isoprostane 54 pharmacokinetic PK profile 54 ARCOXIA 54 Adjusted Ebitda 54 leucopenia 54 Micardis ® 54 otamixaban 54 mg hydrochlorothiazide 54 mcg linaclotide 54 mg/m2/day 54 neutropenia febrile neutropenia 54 Glimepiride 54 Lupuzor ™ 54 dysmenorrhoea 54 concomitant medications 54 Hazard Ratio HR 54 μg liter 54 intravitreal injections 54 recurrent venous thromboembolism 54 umol L 54 diarrhea nausea vomiting 54 Crestor rosuvastatin 54 non hematological toxicities 54 #μg [002] 54 CRESTOR #mg 54 euthyroid 54 HAQ DI 54 ddI 54 R atorvastatin calcium 54 X ULN 54 epoetin beta 54 symptomatic VTE 54 #mmHg [001] 54 suboptimal adherence 54 secondary efficacy endpoint 54 alanine aminotransferase ALT 54 mg dose 54 Acneform rash occurred 54 NIHSS 54 alanine transaminase 54 interferon gamma 1b 54 #ug [002] 54 depressive symptom 54 glycated hemoglobin HbA1c 54 nasopharyngitis headache 54 NIH CPSI 54 ml kg 54 metabolic alkalosis 54 HAM D# scores 54 tegaserod 54 ethambutol 54 lamotrigine 54 % CI #.#-#.# [006] 54 #.#mg/kg [002] 54 salmeterol HFA MDI 54 rimonabant #mg/day 54 inhaled anticholinergics 54 unstable angina pectoris 54 fasting triglycerides 54 glatiramer acetate 54 Platelet counts 54 statistically significant p 54 mg mL 54 T2 lesions 54 LANTUS R 54 mIU L 54 ABILIFY Injection 54 Severity MSCS score 54 clinically meaningful improvement 54 Ejection Fraction 54 creatinine clearance 54 moderate hepatic impairment 54 regression coefficient 54 FROVA 54 MADRS 54 insomnia somnolence 54 tobramycin inhalation solution 54 low dose cytarabine 54 antitrypsin 54 conjunctival hyperemia 54 norethindrone acetate 54 AVODART 54 GI motility 54 zafirlukast 54 atheroma volume 54 beta carotene supplementation 54 NovoLog ® Mix 54 complete cytogenetic response 54 placebo dexamethasone 54 levetiracetam 54 perioperative mortality 54 dose pravastatin 54 Secondary endpoints 54 apnea hypopnea 54 coxib 54 confidence interval #.#-#.# 54 Fluticasone 54 advanced adenoma 54 log# reduction 54 events AEs 54 Erythropoietic therapies may 54 subcutaneous enoxaparin 54 ìg 54 glimepiride 54 RG# #mg 54 LV ejection fraction 54 prolonged QT interval 54 arteriolar 54 Hypotension 54 preintervention 54 serum PTH 54 ml min 54 Global Impression CGI 54 sotalol 54 parecoxib 54 OGTT 54 creatine kinase 54 nondiabetics 54 potassium supplementation 54 BENICAR 54 cells mcL 54 mso header 54 gastric pH 54 zidovudine lamivudine 54 TAXOTERE ® 54 SGOT 54 IXEMPRA 54 pg mL 54 DETROL LA 54 log# IU mL 54 Hamilton Anxiety Scale 54 albumin excretion 54 Score DAS 54 chills fever headache 54 QT intervals 54 ketorolac 54 FOLFOX6 54 nephrotoxic 54 dehydroepiandrosterone sulfate 54 hip BMD 54 reactogenicity 54 serum triglyceride 54 % CI #.#-#.# [007] 54 phonophobia 54 Target Lesion Revascularization TLR 54 Ambrisentan 54 tissue oxygenation 54 CI #.#-#.# [001] 54 CR CRu 54 fluticasone 54 fructosamine 54 hemoglobin A1c levels 54 placebo PBO 54 fluticasone furoate 54 selective non steroidal 54 clopidogrel Plavix 54 Thalomid ® 54 International Prostate Symptom 54 ACTOplus met 54 SBP DBP 54 Telintra 54 eplerenone 54 Biaxin clarithromycin 53 MEVACOR 53 DAS# scores 53 subscores 53 liver transaminases 53 metformin IR 53 severe neutropenia 53 clazosentan 53 inotropic agents 53 incidence ≥ 53 Butrans 53 olanzapine risperidone 53 androgen suppression 53 p = #.# [003] 53 kilogram mg kg 53 pharmacokinetic equivalence 53 LS BMD 53 lactate dehydrogenase LDH 53 ug mL 53 Lopressor 53 Fasting blood glucose 53 cefazolin 53 left ventricular diastolic 53 HoLEP 53 perioperatively 53 #.#ng/ml 53 IELT 53 glipizide plus 53 deoxy 53 lowest tertile 53 Scale EDSS 53 NOAEL 53 serum lipid levels 53 fasting plasma glucose FPG 53 hematologic adverse 53 microbiological eradication 53 Expanded Disability Status 53 Hb A1c 53 biochemical recurrence 53 glomerular filtration 53 colorectal adenoma 53 fluvastatin Lescol 53 #mg dose [001] 53 headache nausea diarrhea 53 statistically significant predictor 53 logMAR 53 elevated alkaline phosphatase 53 μg ml 53 cGy 53 neurologic dysfunction 53 eNO 53 nonfasting 53 nanograms milliliter 53 subscore 53 Peginterferon alfa 2a 53 pegylated liposomal doxorubicin 53 ROZEREM 53 treatment emergent adverse 53 ATACAND 53 unfractionated heparin 53 nmol L 53 enteric coated aspirin 53 dosing frequency 53 #mg/dL [002] 53 mesalamine granules 53 #.#-#.# [011] 53 hypercholesterolaemia 53 gemfibrozil 53 glyburide 53 HMG CoA reductase inhibitors 53 placebo p 53 diastolic blood pressures 53 serum uric acid 53 hemoglobin A1C 53 comparedto 53 vasopressor 53 #.#/#.# mm Hg [003] 53 clinically meaningful reductions 53 gemcitabine Gemzar 53 diarrhea headache nausea 53 Oxy ER 53 troponin T 53 Insulin sensitivity 53 Lucentis monotherapy 53 sirolimus stent 53 AUA BPH Symptom Score 53 highest tertile 53 abdominal pain abdominal discomfort 53 OADs 53 Alkeran 53 echinacea tablets 53 naltrexone SR 53 #mg BID [002] 53 BUPHENYL R sodium phenylbutyrate 53 Preoperatively 53 sustained virological response 53 hypogonadal 53 XIENCE V demonstrated 53 GHRH 53 myopathy rhabdomyolysis 53 urine albumin 53 levalbuterol 53 conventional antipsychotics 53 transaminase levels 53 Zometa hazard 53 cytopenias 53 Vildagliptin 53 mL/min/#.# m2 53 p = ns 53 lumiracoxib 53 diastolic BP 53 fatigue nausea vomiting 53 Apgar scores 53 spine BMD 53 aminotransferase elevations greater 53 HeFH 53 deep venous thromboses 53 beclomethasone dipropionate 53 hepatorenal syndrome 53 adenoma recurrence 53 inert placebo 53 #mg dose [003] 53 antiangiogenic therapy 53 Sandostatin ® 53 intravenous bolus 53 Postoperative complications 53 EQ 5D 53 hypericin 53 everolimus eluting stents 53 clinically evaluable patients 53 EDARBI 53 pmol 53 beclomethasone 53 micromolar 53 irbesartan 53 calculated creatinine clearance 53 Visual acuity 53 TNSS 53 BPH Symptom Score 53 HbA1C 53 Ticlid 53 State Examination MMSE 53 timepoint 53 ZEFFIX 53 mmol liter 53 mmHg systolic 53 mL kg 53 Creatinine 53 ALT flares 53 Adverse effects 53 sedating antihistamine 53 Secondary endpoints included 53 hemagglutination inhibition 53 maximal doses 53 alfa 2a 53 O PPDS 53 severe exacerbations 53 % CI #.#-#.# [004] 53 CK MB 53 PLX STROKE targeting 53 mg Lucentis 53 Psoriasis Area 53 peripheral sensory neuropathy 53 CYPHER ® 53 metformin monotherapy 53 interquartile range 53 diastolic pressures 53 nondepressed 53 haloperidol 53 mcg kg REBETOL 53 carotid IMT 53 risperidone Risperdal 53 Fasting glucose 53 glycated hemoglobin 53 Secondary efficacy endpoints 53 pramipexole 53 Kaplan Meier 53 inhaled fluticasone 53 mometasone 53 plasma lipids 53 Drospirenone 53 plus medroxyprogesterone acetate 53 pharmacodynamic parameters 53 tertiles 53 Q2W 53 parous women 53 postinjury 53 insulin degludec 53 recurrent DVT 53 % CI #.#-#.# [001] 53 pioglitazone Actos 53 hypovolemic 53 dysuria 53 antipsychotic efficacy 53 lumbar spine bone 53 diameter stenosis 53 febrile neutropenia 53 inhospital mortality 53 MenACWY CRM 53 response CCyR 53 plus aztreonam 53 underwent surgical resection 53 brand ciclesonide HFA 53 macroalbuminuria 53 ADHD RS 53 HbA1c levels 53 maximal dose 52 symptomatic hyponatremia 52 terfenadine 52 urate lowering therapy 52 paclitaxel eluting stents 52 Nebulized 52 formoterol fumarate